Table 2 Relation between clinicopathological features and expression of miR-301 and PTEN in ESCC patients
Clinicopathological feature | N | Expression of miR-301 | P value | PTEN mRNA expression | P value | ||
---|---|---|---|---|---|---|---|
High expression (n = 55) | Low expression (n = 55) | High expression (n = 55) | Low expression (n = 55) | ||||
Age (years) | |||||||
> 60 | 84 | 44 | 40 | 0.501 | 41 | 43 | 0.823 |
≤ 60 | 26 | 11 | 15 | 14 | 12 | ||
Gender | |||||||
Male | 78 | 37 | 41 | 0.529 | 36 | 42 | 0.294 |
Female | 32 | 18 | 14 | 19 | 13 | ||
TNM stage | |||||||
I + II | 60 | 20 | 40 | < 0.001 | 38 | 22 | 0.004 |
III | 50 | 35 | 15 | 17 | 33 | ||
LNM | |||||||
No | 71 | 27 | 44 | 0.001 | 38 | 23 | 0.007 |
Yes | 39 | 28 | 11 | 17 | 32 | ||
Tumor size (cm) | |||||||
≥ 5 | 65 | 35 | 30 | 0.438 | 29 | 36 | 0.244 |
< 5 | 45 | 20 | 25 | 26 | 19 | ||
Tumor differentiation | |||||||
Moderate and high differentiation | 78 | 35 | 43 | 0.141 | 44 | 34 | 0.058 |
Poor differentiation | 32 | 20 | 12 | 11 | 21 | ||
Tumor location | |||||||
Upper | 13 | 8 | 5 | 0.556 | 5 | 8 | 0.556 |
Mid-lower | 97 | 47 | 50 | 50 | 47 |